Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-29 @ 5:50 AM
Study NCT ID:
NCT03710603
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-12-24
First Post:
2018-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
Sponsor:
Stichting European Myeloma Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-11
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-08
First Submit QC Date:
None
Study First Post Date:
2018-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-01
Results First Submit QC Date:
None
Results First Post Date:
2024-12-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-16
Last Update Post Date:
2024-12-24
Last Update Post Date Type:
ACTUAL